Transition Metal Dichalcogenides (TMDC)-Based Nanozymes for Biosensing and Therapeutic Applications

Basit Öğe Kaydı
dc.authoridAli Zarrabi / 0000-0003-0391-1769
dc.authoridAtefeh Zarepour / 0000-0002-0347-5840
dc.authorscopusidAli Zarrabi / 23483174100
dc.authorscopusidAtefeh Zarepour / 56700291100
dc.authorwosidAli Zarrabi / U-2602-2019
dc.authorwosidAtefeh Zarepour / DZE-4304-2022
dc.contributor.authorPresutti, D.
dc.contributor.authorAgarwal, T.b
dc.contributor.authorZarepour, A.
dc.contributor.authorCelikkin, N.
dc.contributor.authorHooshmand, S.
dc.contributor.authorZarrabi, Ali
dc.date.accessioned2022-01-18T08:44:02Z
dc.date.available2022-01-18T08:44:02Z
dc.date.issued2022en_US
dc.departmentİstinye Üniversitesi, Mühendislik ve Doğa Bilimleri Fakültesi, Biyomedikal Mühendisliği Bölümüen_US
dc.description.abstractNanozymes, a type of nanomaterial with enzyme-like properties, are a promising alternative to natural enzymes. In particular, transition metal dichalcogenides (TMDCs, with the general formula MX2, where M represents a transition metal and X is a chalcogen element)-based nanozymes have demonstrated exceptional potential in the healthcare and diagnostic sectors. TMDCs have different enzymatic properties due to their unique nano-architecture, high surface area, and semiconducting properties with tunable band gaps. Furthermore, the compatibility of TMDCs with various chemical or physical modification strategies provide a simple and scalable way to engineer and control their enzymatic activity. Here, we discuss recent advances made with TMDC-based nanozymes for biosensing and therapeutic applications. We also discuss their synthesis strategies, various enzymatic properties, current challenges, and the outlook for future developments in this field. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.en_US
dc.identifier.citationPresutti, D., Agarwal, T., Zarepour, A., Celikkin, N., Hooshmand, S., Nayak, C., . . . Maiti, T. K. (2022). Transition metal dichalcogenides (TMDC)-based nanozymes for biosensing and therapeutic applications. Materialsen_US
dc.identifier.doi10.3390/ma15010337en_US
dc.identifier.issn1996-1944en_US
dc.identifier.issue1en_US
dc.identifier.pmid35009484en_US
dc.identifier.scopus2-s2.0-85122237125en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.3390/ma15010337
dc.identifier.urihttps://hdl.handle.net/20.500.12713/2394
dc.identifier.volume15en_US
dc.identifier.wosWOS:000743682600001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorZarrabi, Ali
dc.institutionauthorZarepour, Atefeh
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.relation.ispartofMaterialsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAnticanceren_US
dc.subjectAntimicrobialen_US
dc.subjectBiosensingen_US
dc.subjectCytoprotectionen_US
dc.subjectNanozymesen_US
dc.subjectTransition metal dichalcogenidesen_US
dc.titleTransition Metal Dichalcogenides (TMDC)-Based Nanozymes for Biosensing and Therapeutic Applicationsen_US
dc.typeReview Articleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
246.pdf
Boyut:
2.29 MB
Biçim:
Adobe Portable Document Format
Açıklama:
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Biyomedikal Mühendisliği Bölümü Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu